1st International Conference on Rare Cardiovascular Diseases (Krakow, October 18–19, 2012)
Journal Title: Journal of Rare Cardiovascular Diseases - Year 2013, Vol 1, Issue 2
Abstract
Doctors, like other academic professionals, know very well that there is no better place than a live conference to share knowledge and experience or to interact with people of similar interests.Encouraged by the success of Rare Cardiovascular Diseases (RCD) symposia during the European Society of Cardiology (ESC) Congress in 2011 (Paris) and 2012 (Munich), the team of the Centre for Rare Cardiovascular Diseases (CRCD) in John Paul II Hospital in Krakow organized the 1st International Conference on Rare Cardiovascular Diseases (Krakow, October 18–19, 2012). For two days, the capitol of Kings of Poland became a European capital for rare cardiovascular diseases. Over 350 registered participants from the European and other countries arrived to the newly opened premises of the John Paul II Hospital Education Centre to discuss the vital aspects of care of patients with orphan cardiovascular diseases.
Authors and Affiliations
Piotr Musiałek
Keywords
Related Articles
- EP ID EP245383
- DOI 10.20418/jrcd.vol1no2.83
- Views 116
- Downloads 0
“One of the greatest disease is to be nobody to anybody”
Saint Mother Teresa of CalcuttaDear Readers,Before we go any further, try to ponder the quote once said by the Saint Teresa of Calcutta. She was by far one of the most entitled person in the world to say such an unpleasa...
Evaluation of arterial stiffness in patients with coronary atherosclerosis, cardiac syndrome X and systemic lupus erythematosus (RCD code: I-3C.1)
Objectives: Arterial stiffness manifested by high pulse wave velocity (PWV) consists a risk factor of atherosclerosis and cardio-vascular complications. Systemic lupus erythematosus (SLE) is a generalized autoimmune dise...
Pulmonary arterial hypertension: management in specific medical conditions
Pulmonary arterial hypertension (PAH) is a severe and progressive disease. Due to the narrowing of the blood vessels in the lungs, pul- monary vascular resistance and pulmonary pressures increase. This results in reduced...
Cardiopulmonary exercise tests in rare cardiovascular heart diseases
Cardiopulmonary exercise testing (CPET) is commonly used in clinica practice for both functional and diagnostic assessments of patients with cardiovascular and pulmonary disease. It provides assessment of the integrative...
Doxorubicin cardiomyopathy – case report and review of histopathologic findings (RCD code: III‐1B.5a)
The anthracycline anticancer drug Doxorubicin (Adriamycin) is an effective and frequently used chemotherapeutic agent for various malignancies. The use of doxorubicin is limited by its major adverse effect, cardiotoxicit...